Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles
Neurodegeneration is characterized by progressive loss of structure and function of neurons. Several therapeutic methods and drugs are available to alleviate the symptoms of these diseases. The currently used delivery strategies such as implantation of catheters, intracarotid infusions, surgeries, a...
Main Authors: | Malhotra, Meenakshi, Tomaro-Duchesneau, Catherine, Saha, Shyamali, Prakash, Satya |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590831/ |
Similar Items
-
Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA
by: Malhotra, Meenakshi, et al.
Published: (2013) -
Systemic siRNA Delivery via Peptide-Tagged Polymeric Nanoparticles, Targeting PLK1 Gene in a Mouse Xenograft Model of Colorectal Cancer
by: Malhotra, Meenakshi, et al.
Published: (2013) -
A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis
by: Malhotra, Meenakshi, et al.
Published: (2011) -
Microencapsulation for the Therapeutic Delivery of Drugs, Live Mammalian and Bacterial Cells, and Other Biopharmaceutics: Current Status and Future Directions
by: Tomaro-Duchesneau, Catherine, et al.
Published: (2013) -
The Gut Microbiota and Human Health with an Emphasis on the Use of Microencapsulated Bacterial Cells
by: Prakash, Satya, et al.
Published: (2011)